Polymorphisms in human leukocyte antigen (HLA) and tumor necrosis factor-alpha (TNF-α) have been implicated in CRPS, potentially contributing to an earlier onset and more severe symptoms [48]. The gene discussed is TNF; the disease is complex regional pain syndrome.